MedPath

Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M
Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use .

Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system .

Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea .

Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for:

i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated ;

ii) the active treatment of motion sickness ; and

iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents .

Associated Conditions
Allergic Reaction, Allergic Rhinitis (AR), Allergic cough, Allergy to Tree Pollen, Anaphylaxis, Angioedema, Common Cold, Conjunctival irritation, Cough, Cough Variant Asthma, Cough caused by Common Cold, Eye allergy, Fever, Insect Bites, Insect Stings, Insomnia, Irritative cough, Itching of the nose, Itching of the throat, Motion Sickness, Nasal Congestion, Oral Mucositis, Pain, Parkinsonian Syndromes, Productive cough, Pruritus, Rash, Rhinorrhoea, Sinus Congestion, Sinus headache, Skin Irritation, Sneezing, Sunburn, Symptoms of Acute Bronchitis Accompanied by Coughing, Upper respiratory tract hypersensitivity reaction, site unspecified, Urticaria, Cold or flu syndrome, Dermatographism, Dry cough, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Expectorant

Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2008-01-08
Last Posted Date
2016-05-04
Lead Sponsor
Michelle Kinney
Target Recruit Count
146
Registration Number
NCT00588159
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Papillary Serous Carcinoma of the Endometrium

Phase 2
Completed
Conditions
Endometrial Cancer
Interventions
First Posted Date
2007-08-13
Last Posted Date
2014-07-03
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
30
Registration Number
NCT00515073
Locations
🇺🇸

M. D. Anderson Cancer Center - Orlando, Orlando, Florida, United States

🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics

Terminated
Conditions
Chronic Pain
Interventions
First Posted Date
2007-07-23
Last Posted Date
2020-07-22
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
7
Registration Number
NCT00505531
Locations
🇺🇸

MGH Center for Translational Pain Research, Boston, Massachusetts, United States

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

First Posted Date
2007-06-22
Last Posted Date
2017-03-30
Lead Sponsor
Susan Knox
Target Recruit Count
9
Registration Number
NCT00490009
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Phase 2
Terminated
Conditions
Lymphoma, B-cell
Lymphoma, Non-Hodgkin
Diffuse Large B-cell Lymphoma (DLBCL)
Malignant Lymphoma, Non-Hodgkin
Interventions
Procedure: Autologous hematopoietic stem cell transplantation (auto-HSCT)
Procedure: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
Procedure: Total lymphoid irradiation (TLI)
Drug: Anti-thymocyte globulin (ATG)
First Posted Date
2007-06-04
Last Posted Date
2018-05-14
Lead Sponsor
Stanford University
Target Recruit Count
3
Registration Number
NCT00482053
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

The Montefiore Metoclopramide Study

Phase 4
Completed
Conditions
Nausea
Extrapyramidal Symptoms
Interventions
First Posted Date
2007-05-21
Last Posted Date
2012-12-31
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
289
Registration Number
NCT00475306
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy

Phase 2
Terminated
Conditions
Nausea
Vomiting
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
First Posted Date
2007-02-01
Last Posted Date
2014-07-25
Lead Sponsor
University of South Florida
Target Recruit Count
7
Registration Number
NCT00429702
Locations
🇺🇸

CHRISTUS Santa Rosa Children's Hospital, San Antonio, Texas, United States

🇺🇸

Arnold Palmer Hospital for Children, Orlando, Florida, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

and more 4 locations

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Phase 3
Terminated
Conditions
Lupus Erythematosus, Systemic
Interventions
First Posted Date
2006-09-28
Last Posted Date
2017-08-01
Lead Sponsor
Genentech, Inc.
Target Recruit Count
31
Registration Number
NCT00381810
Locations
🇺🇸

Arizona Arthritis & Rheumatology Research, Pllc, Paradise Valley, Arizona, United States

🇺🇸

Eden Medical Center San Leandro Hospital, San Leandro, California, United States

🇺🇸

Intermountain Research Center, Boise, Idaho, United States

and more 8 locations

Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment

First Posted Date
2006-05-11
Last Posted Date
2021-07-22
Lead Sponsor
British Columbia Cancer Agency
Target Recruit Count
150
Registration Number
NCT00324467
Locations
🇨🇦

BC Cancer Agency, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath